Multiple Sclerosis Clinical Trial

The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders

Summary

This study seeks to determine the biologic causes of inflammation in patients with Transverse Myelitis (TM) Neuromyelitis Optica Spectrum Disorder (NMOSD) and related conditions. While patients will be treated according to decisions with their treating physician, this study will collect data and samples from patients prospectively to gain a better understanding of the disease. We are seeking to understand why some patients respond to medications, while others do not. We also seek to understand what happens biologically, preceding relapses. Gathering these data and samples will allow researchers to identify new ways of diagnosing and treating these diseases. Data and samples will be shared with researchers around the world to support collaborative efforts to treat these conditions.

View Full Description

Full Description

This study seeks to determine the biologic causes of inflammation in patients with Neuromyelitis Optica (NMO), Transverse Myelitis (TM), optic neuritis (ON), related conditions and healthy controls. While patients will be treated according to decisions with their treating physician, this study will collect data and samples from patients prospectively to gain a better understanding of the disease. We are seeking to understand why some patients respond to medications, while others do not. We also seek to understand what happens biologically, preceding relapses. Gathering these data and samples will allow researchers to identify new ways of diagnosing and treating these diseases. Data and samples will be shared with researchers around the world to support collaborative efforts to treat these conditions.

Patients will agree to share medical records, complete questionnaires and donate samples on a timed basis.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Age 6 years or greater
Male or Female
Patient or Parent (in the case of a minor) able to give informed consent
For patients 10 to 17, patient able to assent
Patient diagnosed with NMO, NMOSD, TM or ON

Exclusion Criteria:

Unable to maintain scheduled visits
Patient has known HIV or hepatitis C infection

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

150

Study ID:

NCT01623076

Recruitment Status:

Recruiting

Sponsor:

University of Texas Southwestern Medical Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

The University of Texas Southwestern Medical Center
Dallas Texas, 75390, United States More Info
Benjamin M Greenberg, MD, MHS
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

150

Study ID:

NCT01623076

Recruitment Status:

Recruiting

Sponsor:


University of Texas Southwestern Medical Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.